Vicarious Surgical (RBOT) Current Leases (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Current Leases came in at $1.4 million in Q4 2025, up 17.32% year-on-year from $1.2 million in Q4 2024, and up 5.38% on a QoQ basis from $1.4 million in Q3 2025.
Vicarious Surgical (RBOT) Current Leases (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Current Leases data on file, last reported at $1.4 million in Q4 2025.
- On a quarterly basis, Current Leases rose 17.32% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 17.32% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 17.32% from the prior year.
- Current Leases for Q4 2025 stood at $1.4 million, up from $1.4 million in the prior quarter.
- Over the last five years, Current Leases for RBOT reached as high as $1.4 million in Q4 2025 and fell as low as $4000.0 in Q1 2023.
- Historically, Current Leases has averaged $774388.9 across 5 years, with a median of $1.0 million in 2023.
- Across the five-year window, Current Leases tumbled 91.49% in 2023 and jumped 27100.0% in 2024, its largest moves.
- Year by year, Current Leases stood at $47000.0 in 2021, then plunged by 65.96% to $16000.0 in 2022, then surged by 6443.75% to $1.0 million in 2023, then increased by 16.33% to $1.2 million in 2024, then grew by 17.32% to $1.4 million in 2025.
- Per Business Quant data, the three most recent Current Leases figures were $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 20.50 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 967,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 16,000.00 |
| Sep 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Dec 31, 2021 | 47,000.00 |
| Sep 30, 2021 | 47,000.00 |
| Dec 31, 2020 | 47,000.00 |